Target intelligence / Profile preview

GYG2 antisense RNA 1 (GYG2-AS1)

Target: GYG2-AS1
Molecular classification: Long non-coding RNA (lncRNA)[5], Other

Overview

GYG2 antisense RNA 1 (GYG2-AS1) is a long non-coding RNA gene located on the human genome (Ensembl ID: ENSG00000235483, NCBI Gene: 100873938)[3][5]. It is classified as an lncRNA, meaning it does not encode a protein but may play a regulatory role in gene expression—such as modulating transcription, chromatin structure, or other aspects of cell biology typical for lncRNAs. As of current knowledge and available bioinformatics databases, there is limited published research or functional characterization specific to GYG2-AS1, no established disease relationships, and no known drugs or therapeutic strategies targeting this RNA. There is also no evidence of GYG2-AS1 being a direct therapeutic target such as a receptor, enzyme, or transporter[1][5].

Other names: ENSG00000235483100873938OTTHUMG00000021074.1[3][5]

Mechanism of action

Not characterized[1][5].

Biological functions

Unknown or uncharacterized; typical lncRNA biological functions include potential roles in transcriptional regulation, chromatin remodeling, and cellular signaling, but no explicit function is described for GYG2-AS1 in current database summaries[1][5].

Disease associations

No direct disease association has been established or described in current curated sources as of this time[1][5].

Safety considerations

None identified; no therapeutic interventions targeting this lncRNA are reported[1][5].

Interacting drugs

None reported or characterized[1][5].

Biomarkers

None reported; not currently used as a biomarker for patient selection or efficacy monitoring[1][5].

Beyond the preview

Go deeper on GYG2 antisense RNA 1 (GYG2-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GYG2 antisense RNA 1 (GYG2-AS1).

Explore the full profile